StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report issued on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance NASDAQ:ABIO opened at $1.68 on Friday. ARCA biopharma has a 52 week low of $1.61 and a 52 week high of […]